Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Antibody-drug conjugate therapies in multiple myeloma-what's next on the horizon?Monique Hartley-Brown, Paul RichardsonCurrent Problems in Cancer|January 29, 2022
Plasma cell leukemia: Retrospective review of cases at Monter Cancer Center/Northwell Health Cancer Institute, 2014-2019Christina Cotte, Monique Hartley-BrownHematology. American Society of Hematology. Education Program|December 9, 2023
Considerations for next therapy after anti-CD38 monoclonal antibodies used as first lineMonique Hartley-Brown, Ateh ZinkengCancer Journal (Sudbury, Mass.)|September 22, 2021
Monoclonal Antibodies in Myeloma: Optimizing Targeted TherapyMonique Hartley-Brown, David Chitty, Richa ThakurCase Reports in Hematology|February 27, 2020
Multiple Myeloma in a Young Female Presenting with Neurological SymptomsMatthew Lee, Xinmin Zhang, Vinh Nguyen, et al.Clinical Lymphoma, Myeloma & Leukemia|October 2, 2023
Creating Equitable and Inclusive Clinical Trials for Multiple MyelomaMonique Hartley-Brown, Craig E Cole, Pamela Price, et al.Seminars in Hematology|November 24, 2024
Modernizing multiple myeloma clinical trial eligibility to improve equity and inclusivity by hematological parametersLauren Merz, Monique Hartley-Brown, Maureen Achebe, et al.Expert Opinion on Investigational Drugs|April 23, 2026
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myelomaYuxin Liu, Clifton Mo, Shonali Midha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living GuidelineLisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.Pageof 1